We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers

    Background

    Higher circulating prolactin has been associated with increased breast cancer risk. Prolactin binding to the prolactin receptor (PRLR) can...

    Cassandra A. Hathaway, Megan S. Rice, ... Susan E. Hankinson in Breast Cancer Research
    Article Open access 07 March 2023
  2. Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma

    Neuroblastoma is the most common extracranial childhood solid tumor. The majority of high-risk neuroblastoma is resistant/refractory to the current...

    Xao X. Tang, Hiroyuki Shimada, Naohiko Ikegaki in Genes & Immunity
    Article Open access 07 May 2022
  3. Tumor Microenvironment

    In this chapter, we will learn that the tumor microenvironment is a stroma of normal cells supporting cancer cells. Tumors act like parasites that...
    Carsten Carlberg, Eunike Velleuer, Ferdinand Molnár in Molecular Medicine
    Chapter 2023
  4. An exosome mRNA-related gene risk model to evaluate the tumor microenvironment and predict prognosis in hepatocellular carcinoma

    Background

    The interplay between exosomes and the tumor microenvironment (TME) remains unclear. We investigated the influence of exosomes on the TME...

    Zhonghai Du, **uchen Han, ... Zhiqiang Wang in BMC Medical Genomics
    Article Open access 16 April 2024
  5. Transplantable Subcutaneous Tumor Models

    Mouse tumor models are essential in cancer research, especially in elucidating malignancy, develo** prevention, diagnosis, and new therapeutic...
    Simona Kranjc Brezar in Mouse Models of Cancer
    Protocol 2024
  6. Combined TP53 status in tumor-free resection margins and circulating microRNA profiling predicts the risk of locoregional recurrence in head and neck cancer

    Locoregional recurrences represent a frequently unexpected problem in head and neck squamous cell carcinoma (HNSCC). Relapse often (10–30%) occurs in...

    Federica Ganci, Matteo Allegretti, ... Giovanni Blandino in Biomarker Research
    Article Open access 05 March 2024
  7. Tumor Suppressor Genes

    Tumor suppressors are the second major type of cancer genes. In contrast to oncogenes, tumor suppressor genes have to undergo loss of function to...
    Wolfgang A. Schulz in Molecular Biology of Human Cancers
    Chapter 2023
  8. Tumor-Infiltrating Lymphocyte (TIL) Therapy

    Since T cells can recognize tumor-associated antigens and eliminate cancer cells, preclinical and clinical developments of therapy have been...
    Jeffrey E. Johnson, Velvet R. Van Ryan, Arkadiusz Z. Dudek in The Basics of Cancer Immunotherapy
    Chapter 2024
  9. Integrated analysis of tumor-associated macrophages and M2 macrophages in CRC: unraveling molecular heterogeneity and develo** a novel risk signature

    Background

    Emerging investigations have increasingly highlighted the critical role of tumor-associated macrophages (TAMs) and M2 macrophages in cancer...

    Lu**g Shi, Hongtun Mao, Jie Ma in BMC Medical Genomics
    Article Open access 27 May 2024
  10. NGS-Based Tumor-Informed Analysis of Circulating Tumor DNA

    Accurate circulating tumor DNA (ctDNA) detection has an immense biomarker potential in all phases of the cancer disease course. Presence of ctDNA in...
    Iver Nordentoft, Karin Birkenkamp-Demtröder, Lars Dyrskjøt in Urothelial Carcinoma
    Protocol 2023
  11. Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma

    Circular extrachromosomal DNA (ecDNA) in patient tumors is an important driver of oncogenic gene expression, evolution of drug resistance and poor...

    Owen S. Chapman, Jens Luebeck, ... Lukas Chavez in Nature Genetics
    Article Open access 09 November 2023
  12. Development and validation of postoperative circulating tumor DNA combined with clinicopathological risk factors for recurrence prediction in patients with stage I-III colorectal cancer

    Background

    Circulating tumor DNA (ctDNA) detection following curative-intent surgery could directly reflect the presence of minimal residual disease,...

    Zhaoya Gao, Dandan Huang, ... ** Gu in Journal of Translational Medicine
    Article Open access 30 January 2023
  13. The role of the genomic mutation signature and tumor mutation burden on relapse risk prediction in head and neck squamous cell carcinoma after concurrent chemoradiotherapy

    Personalized genetic profiling has focused on improving treatment efficacy and predicting risk stratification by identifying mutated genes and...

    Hui-Ching Wang, Sin-Hua Moi, ... Li-Tzong Chen in Experimental & Molecular Medicine
    Article Open access 01 May 2023
  14. Introduction to Tumor Ecosystem

    Cancer is a systemic disease. Cancer growth and survival depends on not only the communication between tumor cells and its surrounding, they are also...
    Phei Er Saw, Erwei Song in Tumor Ecosystem
    Chapter 2023
  15. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

    Background

    Genome-wide association studies (GWAS) have identified multiple common breast cancer susceptibility variants. Many of these variants have...

    Thomas U. Ahearn, Haoyu Zhang, ... Nilanjan Chatterjee in Breast Cancer Research
    Article Open access 04 January 2022
  16. Circulating Tumor Cells (CTC) and Tumor-Derived Extracellular Vesicles (tdEV)

    The observation that increasing circulating tumor cell (CTC) and tumor-derived extracellular vesicle (tdEV) load is directly related to worse...
    A. Nanou, P. Beekman, ... L. W. M. M. Terstappen in Circulating Tumor Cells
    Chapter 2023
  17. Advances in Central Nervous System Tumor Classification

    Historically, the classification of tumors of the central nervous system (CNS) relies on the histologic appearance of cells under a microscope;...
    Tathiane M. Malta, James Snyder, ... Ana Valeria Castro in Biological and Clinical Landscape of Meningiomas
    Chapter 2023
  18. Characterization of tumor microenvironment and tumor immunology based on the double-stranded RNA-binding protein related genes in cervical cancer

    Background

    Cervical cancer is one of the most common gynecological cancers threatening women’s health worldwide. Double-stranded RNA-binding proteins...

    ** Li, Chong Wan, ... **aohua Wu in Journal of Translational Medicine
    Article Open access 21 September 2023
  19. Imaging of Tumor-Associated Macrophages

    Tumor-associated macrophages (TAMs) are among the first non-tumoral cells that infiltrate the tumor microenvironment (TME) and encompass up to half...
    Nastaran Khalili, Nima Rezaei in Handbook of Cancer and Immunology
    Living reference work entry 2023
  20. The role of tumor-platelet interplay and micro tumor thrombi during hematogenous tumor metastasis

    Background

    In addition to their pivotal roles in coagulation and thrombosis, platelets are crucial in tumor progression, with plenty of clinical and...

    Qianyu Shi, Tao Ji, ... Wei Guo in Cellular Oncology
    Article 18 January 2023
Did you find what you were looking for? Share feedback.